+44 (0) 8000-148180

Clinical Trial leaded by Professor Yogev

Clinical Trial leaded by Professor Yogev

A research conducted in 2014 at the Beilinson Hospital by Professor Yariv Yogev (Director of Obstetrics and Delivery Ward) examined hundreds of women. Half of the women who participated in the research used Laboraide during birth, and the other half did not. The research goal was to examine the effect of Laboraide on the second stage of labor. Two variants were checked:

The amount of operative intervention during birth among women who give birth for the first time.

The length of the second stage of labor – the pushing stage, which is limited by risks to the mother and child to three hours, after which an operative intervention is needed.

The research results have shown that using Laboraide significantly reduces the need for urgent operative intervention during the second stage of labor (a vacuum delivery or a cesarean section).

Any woman giving birth experiences stress and pain. Placing Laboraide in the mouth during birth prevents the contraction of the jaws, contraction thus opening the airways and leading to the relaxation of the neck and shoulder muscles, reducing the level of stress.

The maximum length allowed for the second stage of labor is 3 hours, after which the need for operative interference becomes immediate duo to an increased risk to both the mother and the baby's health – this is the medical "red line".

The Laboraide-assisted stress relief strengthens the isometric force of the core muscles. This allows women to perform focused and efficient pushing during birth, reducing the chance of crossing the three-hour "red line".

Research Results

Significant decrease in cesarean section deliveries – only 1.2% of the participants who used Laboraide needed a c-section, compared to 6.4% of the women in the control group.

Significant decrease in vacuum deliveries - only 12.3% of the participants who used Laboraide needed a vacuum delivery, compared to 28.2% of the women who did not use the device.

Significant decrease in length of the second stage of labor – only 8.6% of the participants who used Laboraide crossed the three-hour "red line", compared to 24.5% of the participants who did not use Laboraide.

The researchers concluded that using Laboraide among women during the 37th week of pregnancy (or later) can decrease the risk of needing a cesarean section or a vacuum delivery, as shown on the following chart: